...
首页> 外文期刊>Der Kardiologe >Kommentar zu den neuen Leitlinien (2012) der Europäischen Gesellschaft für Kardiologie zur kardiovaskulären Prävention
【24h】

Kommentar zu den neuen Leitlinien (2012) der Europäischen Gesellschaft für Kardiologie zur kardiovaskulären Prävention

机译:对欧洲心脏病学会心血管预防新指南(2012)的评论

获取原文
获取原文并翻译 | 示例

摘要

The new European guidelines on cardiovascular disease (CV) prevention are supported by nine medical societies. They have been restructured, are shorter and more readable. Each subchapter starts with key messages and recommendations are labelled with an evidence level. The subchapter ends with the most important newest information and persisting gaps of evidence for further research. The most important change is the categorization of cardiovascular risk in four levels: low (<1%), medium (1%-<5%), high (5%-<10%) and very high risk (>10%). All patients with CV disease are in the very high risk group with, e.g. a low-density lipoprotein (LDL) cholesterol goal of <70 mg/dl (<1.8 mmol/l). Treatment adherence and behavioral changes can best be achieved by motivational interviews which require some time. The physician has the responsibility for clear recommendations in the discharge summary after hospitalization and for offering help and feedback in the implementation phase of behavioral change.
机译:九个医学会支持新的欧洲预防心血管疾病(CV)指南。它们已经进行了重组,更短且更易读。每个子章节均以关键信息开头,并以证据级别标记建议。本章以最重要的最新信息结尾,并存在持续的证据空白以供进一步研究。最重要的变化是将心血管风险分为四个级别:低(<1%),中(1%-<5%),高(5%-<10%)和极高风险(> 10%)。所有CV疾病患者都属于极高风险人群,例如低密度脂蛋白(LDL)胆固醇目标<70 mg / dl(<1.8 mmol / l)。依从性访谈可能需要一些时间,才能最好地实现治疗依从性和行为改变。医师有责任在住院后出院总结中提供明确的建议,并在行为改变的实施阶段提供帮助和反馈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号